Grade: F — Major Red Flags
Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles
Data: SEC EDGAR 10-K (Filed 2025-08-20, FY ended June 30, 2025) + Yahoo Finance
Auditor: PricewaterhouseCoopers LLP — Unqualified opinion (2 critical audit matters: TOM FORD trademark impairment, goodwill impairment)
One-line verdict: Estee Lauder should be flagged for elimination. This is a prestige beauty company in structural decline: revenue fell 8.2% to $14.3B, the company reported a net loss of $1.13B, operating expenses consumed 79.4% of revenue, and PwC flagged both the $1.8B TOM FORD trademark and goodwill as critical audit matters requiring interim impairment assessments. The filing discloses $1.27B in intangible asset impairment charges and $291M in goodwill impairment in FY2024 alone. Debt/EBITDA is an astronomic 64.8x, reflecting near-zero EBITDA on $9.5B in debt. The company simultaneously settled talcum litigation for $159M and launched a restructuring program. The M-Score of -3.22 is clean — this isn't fraud, it's a business model under severe pressure.
| Metric | Result |
|---|---|
| ❌ Red Flags | **2** (Cash-to-debt, goodwill+intangibles vs equity) |
| ⚠️ Watch Items | **4** (SG&A 89.2%, CFFO/NI negative, leverage 64.8x, soft assets +23.6%) |
| Checks Completed | **17/18** (1 N/A: impairment data) |
| Beneish M-Score | **-3.22** (clean) |
| Auditor | PricewaterhouseCoopers LLP — Unqualified opinion, 2 critical audit matters |
A Prestige Empire Under Siege
Estee Lauder is "one of the world's leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products" with "over 20 luxury and prestige brands." The Lauder family controls approximately 84% of voting power. In February 2025, the company launched "Beauty Reimagined," a strategic restructuring.
| Metric | FY2023 | FY2024 | FY2025 | Trend |
|---|---|---|---|---|
| Net Sales | $15.9B | $15.6B | $14.3B | Declining 3 consecutive years |
| Net Income | $1.0B | $390M | **-$1.13B** | Net loss |
| Gross Margin | 71.3% | 71.7% | 74.0% | Rising (cost cuts) |
| Operating Margin | 11.1% | 6.3% | **-5.5%** | Deep negative |
| SG&A/Revenue | 60.2% | 61.6% | 66.0% | Growing while revenue shrinks |
| Restructuring + Impairment | $262M | $593M | $1,754M | Accelerating charges |
Per the income statement in the filing: "Restructuring and other charges $481M, Goodwill impairment $13M (FY2025) / $291M (FY2024), Impairment of other intangible assets $1,273M (FY2025) / $180M (FY2024), Talcum litigation settlement agreements $159M (FY2025)."
The $1.27B intangible asset impairment in FY2025 is the dominant charge. Gross margin actually improved to 74% as cost of sales fell faster than revenue, but the savings were overwhelmed by restructuring costs, impairment charges, and the talcum settlement.
Cash Flow: Deteriorating Badly
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating Cash Flow | $1,731M | $2,360M | $1,272M |
| Net Income | $1,006M | $390M | -$1,133M |
| **CFFO / Net Income** | **1.72** | **6.05** | **-1.12** |
| CapEx | — | $919M | $602M |
| Free Cash Flow | -$1,558M | $1,441M | $670M |
| Cash | $4,029M | $3,395M | $2,921M |
| Total Debt | $10,169M | $9,826M | $9,467M |
CFFO/NI turned negative because net income turned negative. CFFO itself at $1.27B still provides basic debt service coverage, but it dropped 46% from FY2024's $2.36B. The FY2024 CFFO/NI of 6.05 was inflated by large non-cash impairment charges in the denominator.
Cash on hand of $2.92B is the highest in this 10-company batch, but it covers only 31% of $9.5B in total debt. The company is slowly burning through its cash reserves: $4.0B (FY2023) to $3.4B (FY2024) to $2.9B (FY2025).
The 18-Point Screening
Revenue Quality
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO Change | ✅ | DSO 39 days, -1 day YoY |
| A2 | AR vs Revenue Growth | ✅ | AR -11.4% vs revenue -8.2% |
| A3 | Revenue vs CFFO | ✅ | Revenue -8.2%, CFFO -46.1% |
Revenue quality is clean in relative terms — receivables are declining faster than revenue, and DSO is stable. The CFFO decline is steeper than revenue, but the screening threshold only triggers when revenue grows while CFFO declines.
Expense Quality
| # | Check | Result | Detail |
|---|---|---|---|
| B1 | Inventory vs COGS | ✅ | Inventory -4.6% vs COGS -15.7% |
| B2 | CapEx vs Revenue | ✅ | CapEx -34.5% vs revenue -8.2% |
| B3 | SG&A Ratio | ⚠️ | SG&A/Gross Profit = 89.2% |
| B4 | Gross Margin | ✅ | 74.0%, +2.3pp |
B3 — SG&A consuming 89% of gross profit is the core operational problem. Per the filing, SG&A was $9.46B against revenue of $14.3B (66% of revenue). For a prestige beauty company that depends on advertising, celebrity endorsements, counter staffing, and retail presence, these costs are structurally difficult to cut without damaging brand equity. The "Beauty Reimagined" restructuring attempts to address this.
Cash Flow Quality
| # | Check | Result | Detail |
|---|---|---|---|
| C1 | CFFO vs Net Income | ⚠️ | CFFO/NI = -1.12 (below 1.0) |
| C2 | Free Cash Flow | ✅ | FCF $670M |
| C3 | Accruals Ratio | ✅ | -12.1% |
| C4 | Cash vs Debt | ❌ | Cash $2.9B covers only 31% of debt $9.5B |
C1 is technically a watch item because the negative ratio reflects negative net income rather than negative cash flow. CFFO of $1.27B is positive; the company is generating cash even though it reported a GAAP loss.
Balance Sheet
| # | Check | Result | Detail |
|---|---|---|---|
| D1 | Goodwill + Intangibles | ❌ | $5.9B = 152% of equity |
| D2 | Leverage | ⚠️ | Debt/EBITDA = 64.8x |
| D3 | Soft Asset Growth | ⚠️ | Other assets +23.6% vs revenue -8.2% |
| D4 | Asset Impairment | — | No write-off data |
D2 — Debt/EBITDA of 64.8x is the most extreme reading in this 10-company batch. It reflects near-zero EBITDA ($146M, roughly) against $9.5B in debt. EBITDA was crushed by $1.75B in one-time charges. Normalized EBITDA would produce a ratio closer to 5-6x — still elevated but not existential. Interest coverage of 3.2x is uncomfortably low.
D3 — Soft assets growing 24% while revenue declines 8% suggests the balance sheet is inflating relative to the business. This warrants investigation into what is driving the growth in non-operating assets.
Acquisition Risk
| # | Check | Result | Detail |
|---|---|---|---|
| E1 | Serial Acquirer FCF | ✅ | FCF after acquisitions positive |
| E2 | Goodwill Surge | ✅ | Goodwill+Intangibles -20% YoY (impairment) |
Manipulation Score
| # | Check | Result | Detail |
|---|---|---|---|
| F1 | Beneish M-Score | ✅ | -3.22 (clean) |
Key Risks from the 10-K
1. TOM FORD Trademark — $1.8B Impairment Risk
PwC's first critical audit matter: "The Company's consolidated indefinite-lived intangible assets balance was $3,123 million as of June 30, 2025, of which $1,805 million relates to the TOM FORD trademark. Management concluded that the changes in circumstances in the TOM FORD brand, along with increases in the weighted average cost of capital, triggered the need for an interim impairment review." The TOM FORD trademark alone represents 47% of shareholder equity. The filing notes this is the company's "fiscal 2023 acquisition of the TOM FORD brand."
2. Goodwill — Second Critical Audit Matter
PwC separately flagged goodwill impairment as a critical audit matter. The company recorded $13M in goodwill impairment in FY2025 and $291M in FY2024. Total goodwill stands at $2.14B.
3. Revenue Declining Across All Time Horizons
FY2023: $15.9B, FY2024: $15.6B, FY2025: $14.3B. Three consecutive years of revenue decline totaling 10%. The filing attributes this to global prestige beauty market weakness, travel retail normalization, and competitive pressure. The "Beauty Reimagined" restructuring is a response, not a solution.
4. Talcum Litigation Settlement
The filing discloses $159M in "talcum litigation settlement agreements" in FY2025. This is product liability exposure from legacy talcum powder products. The filing warns of potential future claims.
5. Lauder Family Control
The founding family controls 84% of voting power. This means minority shareholders have effectively no influence over strategic direction, executive compensation, or capital allocation.
6. Restructuring Charges — "Beauty Reimagined"
The filing records $481M in restructuring charges in FY2025, up from $122M in FY2024 and $55M in FY2023. The company warns these "have recorded goodwill and other intangible asset impairment charges in each of the last few fiscal years." The restructuring is ongoing and will generate additional charges.
Summary
Grade: F. Genuine operational deterioration, not just balance sheet mechanics.
Estee Lauder is the only company in this 10-ticker batch where the F grade reflects actual business decline rather than balance sheet engineering or acquisition mechanics. Revenue has fallen 10% over three years, the company reported a $1.13B net loss, SG&A consumes 89% of gross profit, Debt/EBITDA is 64.8x (albeit distorted by one-time charges), and PwC flagged both the $1.8B TOM FORD trademark and goodwill for impairment risk. The company has taken $2.3B+ in cumulative impairment and restructuring charges over FY2024-FY2025. The M-Score of -3.22 confirms this isn't manipulation — it's a prestige beauty franchise losing relevance while carrying the financial burden of the TOM FORD acquisition and $9.5B in debt. The Lauder family's 84% voting control means the turnaround timeline is entirely at their discretion.
**Disclaimer**: This report is based on Estee Lauder's FY2025 10-K filed with SEC EDGAR on August 20, 2025. This is NOT investment advice.
Data: SEC EDGAR 10-K + Yahoo Finance
Auditor: PricewaterhouseCoopers LLP (Unqualified opinion, 2 critical audit matters — TOM FORD trademark, goodwill)
Fiscal year ended: June 30, 2025